Fivetran Launches Hybrid Deployment, Enabling Enterprises to Run Pipelines in Any Environment on a Unified Platform
18.9.2024 10:00:00 CEST | Business Wire | Press release
Hybrid Deployment offers a secure, flexible solution for seamless data movement across environments
Fivetran, the global leader in data movement, today announced Hybrid Deployment, a new solution that allows customers to securely run data pipelines within their own environment from the Fivetran managed platform, providing a single control plane to manage all data sources, whether they are cloud-based SaaS apps or legacy databases with data that needs to be tightly controlled and managed for regulatory or compliance purposes. With the industry’s most comprehensive selection of connectors, destinations and features, Fivetran empowers enterprises to centralize data efficiently, reliably and securely, while supporting governance and compliance requirements and benefiting from 24/7 support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240918100338/en/
Introducing Fivetran’s Hybrid Deployment: A fully managed service that meets the highest enterprise security standards. (Graphic: Business Wire)
Enterprises with sensitive data or in regulated industries often struggle to build data-driven practices. Seamless data access is critical for boosting efficiency, enabling AI-powered analytics and producing reliable data products. Centralizing data can lead to complex, costly systems that burden engineering teams. Traditional SaaS tools often lack the needed control and security, forcing organizations into more cumbersome solutions. DIY or self-hosted solutions often fail to scale effectively, especially as data priorities evolve in the age of AI, resulting in inefficiencies and an urgent need for modernization. Fivetran’s Hybrid Deployment simplifies this by enabling businesses to securely centralize their data and prepare it for AI and machine learning, all while maintaining control over sensitive information.
"Introducing a hybrid cloud deployment model to the Fivetran platform opens up entirely new possibilities for businesses of all sizes," said George Fraser, Fivetran CEO. "Businesses no longer have to choose between managed automation and data control. They can now securely move data from all their critical sources—like Salesforce, Workday, Oracle, SAP, other cloud and on-premises databases and ERPs—into a data warehouse or data lake, all while keeping that data under their own control. This is especially valuable for industries like healthcare and life sciences and financial services, where secure, compliant and reliable data is critical."
How Hybrid Deployment works
Hybrid Deployment keeps sensitive data within the customer’s environment while taking advantage of Fivetran’s management and monitoring tools. A lightweight local connector securely moves the data, while Fivetran’s user-friendly interface makes configuration and monitoring simple, all from a single control plane.
"Fivetran's new hybrid deployment option is a game-changer. Now customers can easily centralize all their data, regardless of security or compliance requirements, given the ability to separate the control and data plane,” said Vinay Kumar Katta, Managing Delivery Architect, Capgemini. “Customers will appreciate Fivetran's best-in-class platform that offers the flexibility to choose how and where their pipelines run. We're excited to advance our partnership with Fivetran and help more enterprises modernize their data infrastructure."
The separate control and data plane architecture ensures data never leaves the customer’s secure environment, giving them ultimate control over how their data is moved while still benefiting from Fivetran’s managed platform. This solution automates and centralizes the data movement process, while also giving enterprises the benefits of:
- Full visibility: Monitor all pipelines from a single interface.
- Data security: Control access, mask sensitive data and track movement to ensure compliance.
- Compatibility across environments: Works across AWS, Microsoft Azure, Google Cloud, and on-premises environments.
- Simple setup: Quick installation with no complex maintenance required.
- Flexibility: Scale and customize pipelines with integrations for APIs and tools like Terraform.
- Cost management: Track usage and control budgets with detailed reporting tools.
"phData is excited about Fivetran's new Hybrid Deployment option, which allows our customers in regulated industries like healthcare, life sciences and financial services to scale the configuration and ingestion of highly sensitive datasets on self-managed infrastructure," said Troy Fokken, Chief Architect at phData. "This approach streamlines the data pipeline processes, as customers don't need to self-host software or build DIY pipelines to securely move data from source systems to destination."
As government regulations like GDPR, HIPAA and CCPA continue to tighten, and new ones emerge, enterprises are increasingly focused on ensuring their data practices meet strict security and compliance standards. Recent breaches in healthcare and financial services have highlighted the risks of exposing sensitive information and compromising critical systems. DIY or self-managed pipelines can introduce vulnerabilities, especially as teams must frequently make updates in order to meet rapidly changing data schema, which increases the risk of errors that can lead to data breaches. Fivetran’s Hybrid Deployment mitigates these risks by providing a managed solution that runs within the customer’s secure environment, ensuring compliance while eliminating common points of failure.
“The simplicity of management is the best value of Hybrid Deployment,” said Ajay Bidani, Data and Insights Manager at Powell Industries. “I know the status of our pipelines and can launch and manage cloud-based and on-premises pipelines directly from one platform. Given our history with on-premises applications, I can say that pipelines going down and requiring restart was quite cumbersome, but Hybrid Deployment has been considerably different. I can realize the ease of monitoring and maintaining pipelines with immediacy. The ability to quickly stand up Hybrid Deployment for on-premises data movement, while managing it from a straightforward and familiar cloud-based control plane, is a great value add.”
Reducing complexity for engineering teams
Hybrid Deployment reduces manual setup and maintenance, allowing engineering teams to focus on building data-driven solutions. Fivetran handles the heavy lifting, helping businesses extract value from their data without worrying about brittle DIY infrastructure. A recent report by IDC found that enterprises can realize an average annual productivity gain of $1.5 million by transitioning to Fivetran’s managed data movement solution.
Fivetran’s data integration platform can handle high-volume change data capture from databases and offers 600+ pre-built connectors for a range of SaaS applications, events, files, ERPs, data warehouses and data lakes. The Fivetran platform replicates data with minimal impact on source systems, low latency and high throughput, making it the trusted choice for over 6,300 customers globally. With the richest technical feature set of any data ingestion tool, Fivetran meets the widest range of data integration use cases.
To learn more, visit the Fivetran blog or explore images and assets in the Fivetran newsroom. You can also start your free Hybrid Deployment trial today at Fivetran.com.
About Fivetran
Fivetran, the global leader in data movement, helps customers use their data to power everything from AI applications and ML models, to predictive analytics and operational workloads. The Fivetran platform reliably and securely centralizes data from hundreds of SaaS applications and databases into any cloud destination — whether deployed on-premises, in the cloud or in a hybrid environment. Thousands of global brands, including Autodesk, Condé Nast, JetBlue and Morgan Stanley, trust Fivetran to move their most valuable data assets to fuel analytics, drive operational efficiencies and power innovation. For more info, visit fivetran.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240918100338/en/
Contacts
Matias Cavallin
Matias Cavallin
323-715-0020
matias.cavallin@fivetran.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom